Cite
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
MLA
Brufsky, Adam M., et al. “Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from RegistHER.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 17, no. 14, July 2011, pp. 4834–43. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-10-2962.
APA
Brufsky, A. M., Mayer, M., Rugo, H. S., Kaufman, P. A., Tan-Chiu, E., Tripathy, D., Tudor, I. C., Wang, L. I., Brammer, M. G., Shing, M., Yood, M. U., & Yardley, D. A. (2011). Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(14), 4834–4843. https://doi.org/10.1158/1078-0432.CCR-10-2962
Chicago
Brufsky, Adam M, Musa Mayer, Hope S Rugo, Peter A Kaufman, Elizabeth Tan-Chiu, Debu Tripathy, Iulia Cristina Tudor, et al. 2011. “Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from RegistHER.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 17 (14): 4834–43. doi:10.1158/1078-0432.CCR-10-2962.